Ilika Enters Commercial Phase with First Stereax Electrode Order from Cirtec Medical

Ilika plc ( (GB:IKA) ) has provided an announcement.

Ilika has secured its first revenue-generating purchase order from Cirtec Medical for Stereax electrodes, marking the transition of their strategic partnership from technology transfer to commercial production. The electrodes will underpin the ramp-up of Stereax M300 battery manufacturing at Cirtec’s Massachusetts facility, targeting a broad spectrum of active implantable medical device applications, from implanted sensors and neurostimulators to orthopaedic, orthodontic and ophthalmic devices. This move follows two years of joint development and successful prototype deliveries in late 2025, and signals Ilika’s entry into the commercial phase of its medical device battery business, with Stereax M300 currently under evaluation by 21 customers. By retaining key manufacturing processes in the UK while supplying production volumes of critical components to Cirtec, Ilika is positioning itself to benefit from Cirtec’s scale-up and to deepen penetration of high-value medical markets, with the partnership’s commercial readiness to be highlighted at upcoming US industry events.

The most recent analyst rating on (GB:IKA) stock is a Hold with a £37.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Spark’s Take on GB:IKA Stock

According to Spark, TipRanks’ AI Analyst, GB:IKA is a Neutral.

Ilika plc’s overall stock score is primarily influenced by its financial challenges and bearish technical indicators. However, the company’s strategic advancements in solid-state battery technology and collaborations with industry partners provide a positive outlook for future growth. The valuation remains unattractive due to negative earnings, but corporate events suggest potential for long-term improvement.

To see Spark’s full report on GB:IKA stock, click here.

More about Ilika plc

Ilika plc is a UK-based pioneer in solid-state battery technology, developing next-generation solutions for electric vehicles, medical devices and consumer appliances. The company’s portfolio includes miniature Stereax batteries for implantable medical devices, industrial wireless sensors and IoT applications, and Goliath large-format batteries for EVs and cordless appliances, commercialised primarily through a licensing model with OEMs and manufacturing partners.

Average Trading Volume: 181,384

Technical Sentiment Signal: Sell

Current Market Cap: £68.72M

For a thorough assessment of IKA stock, go to TipRanks’ Stock Analysis page.